Optimizing Pharmacologic Treatment for Neonatal Opioid Withdrawal Syndrome (OPTimize NOW): A Symptom-Based Dosing Approach

PHASE3Active, not recruitingINTERVENTIONAL
Enrollment

480

Participants

Timeline

Start Date

March 25, 2024

Primary Completion Date

May 27, 2025

Study Completion Date

August 27, 2025

Conditions
Neonatal Opiate Withdrawal Syndrome
Interventions
OTHER

Symptom-based Dosing Approach

During this approach to care, all enrolled infants with NOWS at the study site will be treated with the symptom-based dosing approach if they meet the withdrawal threshold for pharmacologic treatment. Participants may receive up to 3 doses of the study site's preferred opioid during a 24-hour period to treat signs of withdrawal once the threshold for pharmacologic intervention is met. If a 4th dose is required within a 24-hour period, the study site will transition to the scheduled opioid taper algorithm used at the study site to complete the infant's pharmacologic treatment.

OTHER

Scheduled Opioid Taper Approach

During this approach to care, all enrolled infants with NOWS at the study site will be treated with the study site's usual scheduled opioid taper approach, as detailed in each site's treatment algorithm, if they meet the withdrawal threshold for pharmacologic treatment.

Trial Locations (23)

14642

University of Rochester Medical Center, Rochester

19104

Children's Hospital of Philadelphia, Philadelphia

19107

Pennsylvania Hospital, Philadelphia

Thomas Jefferson University Hospital, Philadelphia

19801

ChristianaCare, Wilmington

33606

University of South Florida Health, Tampa

35294

University of Alabama at Birmingham, Birmingham

40202

Norton Children's Hospital, Louisville

40207

Norton Women's and Children's Hospital, Louisville

40536

Kentucky Children's Hospital, Lexington

41017

St. Elizabeth Healthcare, Edgewood

45202

Good Samaritan Hospital, Cincinnati

45229

Cincinnati Children's Hospital Medical Center, Cincinnati

45429

Kettering Health Main Campus, Kettering

46202

Sidney & Lois Eskenazi Hospital, Indianapolis

47130

University of Louisville Hospital, Jeffersonville

66160

University of Kansas Hospital, Kansas City

68198

University of Nebraska Medical Center, Omaha

72205

University of Arkansas for Medical Sciences, Little Rock

73104

Oklahoma Children's Hospital OU Health, Oklahoma City

84158

University of Utah Health, Salt Lake City

87131

University of New Mexico Health Sciences Center, Albuquerque

08401

AtlantiCare Regional Medical Center, Atlantic City

All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

collaborator

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

NIH

lead

HELP for NOWS Consortium

NETWORK

NCT05980260 - Optimizing Pharmacologic Treatment for Neonatal Opioid Withdrawal Syndrome (OPTimize NOW): A Symptom-Based Dosing Approach | Biotech Hunter | Biotech Hunter